Javascript must be enabled to continue!
Immunohistochemical expression of IL‐10 in mycosis fungoides
View through CrossRef
Abstract Immunoreactivity of the cytokine IL‐10 has been investigated in situ in mycosis fungoides (MF). Expression of IL‐10 was detected using immunohistochemistry in skin biopsies (n=8) and T‐cell lines (n= 2) from mycosis fungoides patients. IL‐10 positivily was seen in the dermal cell infiltrates and in T‐cell lines in mycosis fungoides. The dermal IL‐10 reaction in a skin biopsy from an active lesion in MF indicates the possibility for disease progression.
Title: Immunohistochemical expression of IL‐10 in mycosis fungoides
Description:
Abstract Immunoreactivity of the cytokine IL‐10 has been investigated in situ in mycosis fungoides (MF).
Expression of IL‐10 was detected using immunohistochemistry in skin biopsies (n=8) and T‐cell lines (n= 2) from mycosis fungoides patients.
IL‐10 positivily was seen in the dermal cell infiltrates and in T‐cell lines in mycosis fungoides.
The dermal IL‐10 reaction in a skin biopsy from an active lesion in MF indicates the possibility for disease progression.
Related Results
Thyroid Dysfunction in Mycosis Fungoides: Sonographic and Laboratory Insights
Thyroid Dysfunction in Mycosis Fungoides: Sonographic and Laboratory Insights
Introduction: Thyroid gland affection in mycosis fungoides has been rarely reported. It occurs as extracutaneous involvement, incidentally, as a second malignancy, or as a side eff...
CD4/CD8 double-negative mycosis fungoides: a review
CD4/CD8 double-negative mycosis fungoides: a review
Mycosis Fungoides (MF) stands as the predominant form of primary cutaneous T-cell lymphoma (CTCL). It manifests a diverse array of clinical, histological, and immunophenotypic vari...
Prognostic Value of Immunohistochemical T-Cell Marker Loss in Early-Stage Mycosis Fungoides: A Single-Center Cohort Study
Prognostic Value of Immunohistochemical T-Cell Marker Loss in Early-Stage Mycosis Fungoides: A Single-Center Cohort Study
Introduction: Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma, often exhibiting loss of pan-T-cell markers such as CD2, CD3, CD5, and CD7. While these immunophe...
Mycosis Fungoides: A differential diagnosis to consider for lichenoid keratosis
Mycosis Fungoides: A differential diagnosis to consider for lichenoid keratosis
Mycosis fungoides (MF) has a wide spectrum of presentation. Its clinic is polymorphic, leading to several clinical variants. Chronic diffuse hyperpigmented lesions can be found in ...
Folliculotropic mycosis fungoides: clinical and epidemiological evaluation in a single center in Brazil
Folliculotropic mycosis fungoides: clinical and epidemiological evaluation in a single center in Brazil
AbstractBackgroundFolliculotropic mycosis fungoides (FMF) is a rare variant of mycosis fungoides with clinical peculiarities, refractoriness to conventional treatments, and worse p...
Bleomycin Therapy in Mycosis fungoides
Bleomycin Therapy in Mycosis fungoides
Nine patients with mycosis fungoides in different stages were treated with Bleomycin. Much better results were obtained with this new drug in the six patients with the infiltrative...
Pediatric Hypopigmented Mycosis Fungoides: A Narrative Literature Review of Phototherapy Dosing Regimens
Pediatric Hypopigmented Mycosis Fungoides: A Narrative Literature Review of Phototherapy Dosing Regimens
Background
Mycosis fungoides is the most common type of childhood‐onset primary cutaneous T‐cell lymphoma, and hypopigmented mycosis fungoides (hMF) is a rare, ...
Photochemotherapy in mycosis fungoides.
Photochemotherapy in mycosis fungoides.
Six patients with mycosis fungoides were treated with methoxsalen and long-wave ultraviolet light. They were assessed clinically and histologically before and after treatment. All ...

